1. NDMA-contaminated ranitidine products recalled

   News item 19 October 2019 Pages: 1 - 1

2. PRAC recommends limiting use of high-strength estradiol creams

   News item 19 October 2019 Pages: 2 - 2

3. ACE inhibitor-associated psoriasis

   Clinical study 19 October 2019 Pages: 3 - 3

4. Antidepressant use appears safe

   Clinical study 19 October 2019 Pages: 4 - 4

5. Antipsychotic use in Alzheimer's disease increases hospital days

   Clinical study 19 October 2019 Pages: 5 - 5

6. Benzodiazepines increase risk of cognitive dysfunction in elderly

   Clinical study 19 October 2019 Pages: 6 - 6

7. Brexpiprazole-related metabolic changes and weight gain

   Clinical study 19 October 2019 Pages: 7 - 7

8. Ipilimumab/nivolumab-related steroid-refractory toxicities

   Clinical study 19 October 2019 Pages: 8 - 8

9. Neural tube defects after exposure to antiretrovirals

   Clinical study 19 October 2019 Pages: 9 - 9

10. New or worsening hypertension with ibrutinib

    Clinical study 19 October 2019 Pages: 10 - 10

11. No new safety signals for GSK's influenza vaccine

    Clinical study 19 October 2019 Pages: 11 - 11

12. Preterm birth risk with oral corticosteroids

    Clinical study 19 October 2019 Pages: 12 - 12

13. Abatacept

    Case report 19 October 2019 Pages: 13 - 13

14. Acitretin

    Case report 19 October 2019 Pages: 14 - 14

15. Acitretin/cefazolin

    Case report 19 October 2019 Pages: 15 - 15

16. Actinium-225 DOTATATE

    Case report 19 October 2019 Pages: 16 - 16

17. Adalimumab

    Case report 19 October 2019 Pages: 17 - 17

18. Adalimumab

    Case report 19 October 2019 Pages: 18 - 18

19. Adalimumab

    Case report 19 October 2019 Pages: 19 - 19

20. Adalimumab/antituberculars

    Case report 19 October 2019 Pages: 20 - 20

21. Adalimumab/methotrexate

    Case report 19 October 2019 Pages: 21 - 21

22. Adalimumab/secukinumab/ustekinumab

    Case report 19 October 2019 Pages: 22 - 22

23. Aflibercept

    Case report 19 October 2019 Pages: 23 - 23

24. Aflibercept

    Case report 19 October 2019 Pages: 24 - 24

25. Alemtuzumab

    Case report 19 October 2019 Pages: 25 - 25

26. Alemtuzumab

    Case report 19 October 2019 Pages: 26 - 26

27. Alendronic acid

    Case report 19 October 2019 Pages: 27 - 27

28. Alendronic-acid/pamidronic-acid

    Case report 19 October 2019 Pages: 28 - 28

29. Allopurinol

    Case report 19 October 2019 Pages: 29 - 29

30. Allopurinol/fluindione interaction

    Case report 19 October 2019 Pages: 30 - 30

31. Alprazolam

    Case report 19 October 2019 Pages: 31 - 31

32. Alprazolam abuse/overdose

    Case report 19 October 2019 Pages: 32 - 32

33. Alteplase

    Case report 19 October 2019 Pages: 33 - 33

34. Alteplase

    Case report 19 October 2019 Pages: 34 - 34

35. Ambrisentan

    Case report 19 October 2019 Pages: 35 - 35

36. Amikacin/azithromycin/imipenem

    Case report 19 October 2019 Pages: 36 - 36

37. Amiodarone

    Case report 19 October 2019 Pages: 37 - 37

38. Amiodarone

    Case report 19 October 2019 Pages: 38 - 38

39. Amiodarone

    Case report 19 October 2019 Pages: 39 - 39

40. Amiodarone

    Case report 19 October 2019 Pages: 40 - 40

41. Amiodarone

    Case report 19 October 2019 Pages: 41 - 41

42. Amiodarone/thiamazole

    Case report 19 October 2019 Pages: 42 - 42

43. Amisulpride/paliperidone

    Case report 19 October 2019 Pages: 43 - 43

44. Amitriptyline overdose

    Case report 19 October 2019 Pages: 44 - 44

45. Amitriptyline/phenytoin

    Case report 19 October 2019 Pages: 45 - 45

46. Amlodipine

    Case report 19 October 2019 Pages: 46 - 46

47. Amlodipine overdose

    Case report 19 October 2019 Pages: 47 - 47

48. Amlodipine overdose

    Case report 19 October 2019 Pages: 48 - 48

49. Amlodipine overdose

    Case report 19 October 2019 Pages: 49 - 49

50. Amlodipine/atorvastatin/ticagrelor interaction

    Case report 19 October 2019 Pages: 50 - 50